The prescription-only S4
drug Clenbuterol, used as a
bronchodilator in horses and
by athletes as a performance
enhancer, is increasingly being used
by the general public.
A study published in the Medical
Journal of Australia found 63
cases of clenbuterol exposures
over nine years of data from the
NSW Poisons Information Centre,
with a “dramatic increase” from
three cases in 2008 to 27 in 2012,
with 84% of patients requiring
hospitalisation.
Researcher Dr Jonathan Brett said
there were arguments to restrict
sales by puting the drug into the
same category as benzodiazepines
and anabolic steroids.The above article was sent to subscribers in Pharmacy Daily's issue from 06 Mar 14 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 06 Mar 14
DEMENTIA Australia has appointed comedian Geraldine Hickey (pictured) as its newest Ambassador, coinciding with the Melbourne Memory Walk & Jog event taking place this Sun.
NEW research from the Monash Addiction Research Centre has highlighted a critical shortfall in the availability of Naloxone, a life-saving medication that reverses opioid overdoses, across community pharmacies in Australia’s most populous states.
THE Senate’s Community Affairs Legislation Committee is holding a two-day inquiry into the Therapeutic Goods and Other Legislation Amendment (Vaping Reforms) Bill 2024, which is currently under discussion in Federal Parliament.
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.